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THE effect of lyso-PAF on ciliated cells was investigated
in vitro. Normal mucosa was surgically obtained from
human paranasal sinuses and incubated in the form of
tissue culture. Ciliated epithelium was magnified under
an inverted microscope, and ciliary movement was
photo-electrically measured. Ciliary activity was signi-
ficantly inhibited by 10-SM lyso-PAF and could be
restored. The effect of lyso-PAF was completely blocked
by CV-6209, a specific PAF antagonist. The PAF
concentration in the incubation medium of lyso-PAF was
determined by radioimmunoassay, because PAF is a well
known inhibitor of ciliary activity. PAF gradually
increased and after 20 min reached its maximal level.
These findings indicated the existence of an enzyme in the
paranasal sinus mucosa, by which lyso-PAF is converted
to PAF, and that lyso-PAF can inhibit ciliary activity by
means of PAF.
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Introduction
Platelet activating factor (PAF) is considered to
be a potent chemical mediator which can induce
various features in allergic and inflammatory
disorders of the respiratory tract. Inhaled PAF
causes rhinitis-like symptoms, bronchial constric-
tion and prolonged airway hyperresponsiveness.2’3
PAF also induces release of mucus from tracheal
submucosal glands
4 and dysfunction of ciliated
cells in vitro. However, lyso-PAF, which is a
precursor and metabolite of PAF, is thought to
have minimal effect compared with PAF. There are
few reports detailing the effect of lyso-PAF on
ciliary activity,, because it was considered to be
inactive in the biological system. The authors
observed ciliary activity of human paranasal sinus
mucosa, which is a part of the respiratory
epithelium, by incubating the mucosa with
lyso-PAF. In this paper, the effect of lyso-PAF on
ciliary activity is described and the cause of its effect
is discussed.
Materials and Methods
Maintenance of human paranasal sinus mucosa: Normal
paranasal sinus mucosa was carefully removed by
surgical procedure from the ethomidal sinuses of
patients who suffered from facial trauma. The
mucosa was rinsed in Eagle’s minimal essential
medium (MEM) to remove blood cells and mucus,
and cut into pieces of approximately 4 mm x 4 mm
with scissors. The mucosal specimens were
examined by light microscopy, transferred onto a
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collagen layer in 35 mm x 10 mm culture dishes
containing 1 ml of Eagle’s MEM with 10% foetal
calf serum (FCS), and incubated at 37C under 5%
CO2 in a 100% humidified incubator. The culture
medium was changed 24 h later to remove mucus
and cellular debris, and every 48 h thereafter. These
experiments were conducted with the under-
standing and consent of the patients and/or their
families.
PA F, lyso-PAF and PAF antagonist: 1-O-hexadecyl-2-
acetyl-sn-glycero-3-phosphorylcholine (PAF) and 1-
O-hexadecyl-sn-glycero-3-phosphorylcholine (lyso-
PAF) were used (Bachem Feinchemikalien AG,
Bubendorf, Switzerland). PAF and lyso-PAF were
dissolved in methanol at a concentration of 10-2M
and then diluted with Eagle’s MEM to 10
-8 M.
CV-6209 (2-[N-acetyl-N-(2-methoxy-3-octadecyl-
carbamoyl-oxy-propoxy-carbonyl) aminomethyl]-l-
ethylpyridinium chloride (Takeda Chemical In-
dustries Ltd, Osaka, Japan)), a highly specific PAF
inhibitor,
6 was used. CV-6209 was dissolved in
physiological saline at 10
-3 M and then diluted with
the medium. Each test solution consisted of 1.5 ml
to which the mucosal specimens were exposed.
Observation and recording of ciliary activity: The mucosal
specimen was irrigated three times with Eagle’s
MEM without FCS before exposure to each test
solution. Ciliated cells on the mucosal epithelium,
at 37C under 5% CO2, were magnified under an
inverted microscope equipped with a camera, and
observed on the TV monitor. Ciliary activity of
each ciliated cell was recorded on video tape and
photo-electrically measured by placing a 3 mm wide
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photo-sensor on each beating bundle of cilia which
was displayed on the TV monitor.
Radioimmunoassay ofPAF: The concentration of PAF
in the culture medium was measured using a
PAF[lesI] radioimmunoassay kit (E. I. DuPont de
Nemours & Co., Boston, USA). All procedures
were carried out using polypropylene pipette tips
and polystyrene tubes for assay. To each tube,
100 #1 of each sample to be tested and 100 #1 ofPAF
primary antibody were added followed by g 15 min
incubation period at room temperature, and then
100 #1 of the secondary antibody/tracer solution
were added followed by an 18 min incubation at
room temperature. After the addition of 2 ml of
assay buffer (50 mM sodium citrate buffer contain-
ing 0.1% sodium azide and 0.05% Tween 20, pH
6.3), the tubes were centrifuged at 2000 x g for
30 rain at room temperature and then decanted. The
remaining radioactivity was counted by the r-well
counter. The concentrations of PAF in the test
samples were determined from the calibration
curve.
Statistical analysis: The significant dit:ference between
recorded values was statistically determined at
p < 0.01 on the Student’s t-test for unpaired data.
Results
Effect of lyso-PAF: Five mucosal specimens obtained
from five patients (A to E) were exposed to 10
-8 M
lyso-PAF. The time courses of the effect of 10
-8 M
lyso-PAF are illustrated in Fig. 1. Ciliary activity
was inhibited after 1 h of exposure in Specimen A,
2hinB, 5hinCandD, and7hinE. There was
a significant difference between the ciliary beat
frequency during the initial activity (zero time) and
its lowest level of activity in each specimen.
However, the ciliary beat frequency in each
I
4 6 8 10
Time (h)
FIG. 1. The time course of ciliary activity exposed to 10-8 M lyso-PAF.
The values are expressed as means and S.D. Ten ciliated cells of each
specimen (A to E) were observed. *p < 0.01, compared with the initial
ciliary activity., (C) Patient A; /, Patient B; r-I, Patient C; O, Patient D;
A, Patient E.
specimen recovered from its lowest level of activity.
Consequently, inhibition was temporary and
reversible.
Effect of CV-6209: CV-6209, which is a specific PAF
receptor antagonist, inhibited the effect of PAF and
lyso-PAF on ciliary activity (Fig. 2). Significant
ciliary inhibition was time dependently induced by
10-8 M PAF. When the mucosa was incubated with
10
-8 M PAF and 10
-6 M CV-6209 after a 15 min
preincubation with 10-6 M CV-6209, ciliary activity
showed no remarkable change for 10 h. However,
a concentration of 10
-8 M CV-6209 was not enough
to inhibit the effect of 10-8M PAF on ciliary
activity. Ciliary activity was moderately inhibited
by PAF when the mucosa was incubated with
10-8 M PAF and 10-8 M CV-6209 after a 15 min
preincubation with 10-8M CV-6209. When the
mucosa was incubated with 10-8M lyso-PAF,
ciliary activity was significantly inhibited after 5 h
of exposure and restored after 10 h. Furthermore,
the effect of 10-8 M lyso-PAF on ciliary activity was
completely blocked by 10-6M CV-6209. In these
experiments (Fig. 2), specimens from Patient C were
used. The time course is illustrated in Fig. 1.
Time course ofPAF in the culture medium: Assays of PAF
in the incubation chamber, when the mucosa was
incubated with 10-8M PAF, were carried out. A
time dependent decrease in PAF concentration in
the tissue culture medium (Fig. 3) was observed.
PAF concentration was halved within 11.4 min, and
within 60 min, its concentration was only 3.2% of
the initial concentration.
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FIG. 2. Effects of PAF, lyso-PAF and CV-6209 on ciliary activity of human
paranasal sinus mucosa in vitro. The values are expressed as means and
S.D. n=10. *, (*): p<0.01. I, 10-6 CV-6209+10-SM PAF; r-I,
10-8 M CV-6209 + 10-8 M PAF;., 10-8 M PAF alone; i, 10-6 M
CV-6209 + 10-8m lyso-PAF; [], 10-8 M lyso-PAF alone.
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FIG. 4. The time course of PAF concentration in the incubation medium
when the mucosa was incubated with 10-8 M lyso-PAF. The bars are
expressed as means, n 6. *p < 0.01.
mean of PAF concentration reached the maximum
of 0.273 x 10-8M. However, PAF was not
detected after 60 min.
Discussion
Ciliary activity was significantly inhibited by
lyso-PAF and could be restored in all five specimens
(Fig. 1). There were some differences in the time at
which ciliary activity was inhibited in each
specimen. The earliest was 1 h, the latest was 7 h,
and the average of five experiments was 4 h. The
inhibition in ciliary activity induced by lyso-PAF
were irregular. However, the effect of lyso-PAF on
ciliary activity was completely blocked by CV-6209,
which is a specific PAF antagonist (Fig. 2).
Furthermore, PAF was detected in the culture
medium when the paranasal sinus mucosa was
incubated with lyso-PAF (Fig. 4). The mean ofPAF
concentration reached its maximal level after 20 min
incubation. There was a significant dierence
between the concentrations of PAF at the initial
time (zero time) and at 20 min. These results
indicate that lyso-PAF was converted to PAF,
which then induced ciliary inhibition.
Acetyltransferase activity, which can change
lyso-PAF to PAF, has been found in various rat
tissues,
7 murine macrophages,
8 and human neu-
trophils and eosinophils.
1 One of the enzymes in
the paranasal sinus mucosa was supposed to
produce PAF from lyso-PAF. The concentrations
of secondary PAF in the culture medium were
variable. The formation of PAF was suspected to
depend on lyso-PAF as a substrate and the
converting enzyme. The respective pieces of
mucosal volume were not strictly constant and the
activity of the converting enzyme in each mucosa
might be variable. Therefore, the peak concentra-
tions of newly generated PAF appeared to be
variable. It is supposed that such various
concentrations of secondary PAF induced the
variety of the maximum of ciliary inhibition. The
earlier the concentration at which PAF reached its
peak, the earlier the inhibition in ciliary activity
appeared. The higher the concentration of PAF, the
stronger the inhibition of ciliary activity became.
However, the concentration of PAF in the culture
medium was rapidly reduced by half within
11.4 min, and within 60 min most of the PAF was
diminished (Fig. 3). PAF could have an effect on
ciliated cells for only a short period of time.
In a previous study
1 ciliary dysfunction is
induced primarily within the first 60min after
exposure to PAF. PAF is unstable, and easily
converted to an inactive metabolite. It is uncertain
whether the reduction of PAF in the medium was
achieved enzymatically by acetylhydrolase
2 or
non-enzymatically by environmental agents, such as
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temperature and light. In this study, the PAF
formed by conversion of lyso-PAF and detected in
the culture medium decreased rapidly, and ciliary
inhibition was reversible.
PAF is one of the most important mediators
which can induce mucosal damage and respiratory
hyperresponsiveness. It may be necessary to
investigate the more detailed mechanisms of the
conversions between lyso-PAF and PAF. However,
the findings obtained from the present study
support the proposal that an enzyme which
converts lyso-PAF to PAF exists in human
paranasal sinus mucosa. Furthermore, lyso-PAF is
secondarily capable of inhibiting ciliary activity.
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